Dr Nicola Mulholland
Consultant in Nuclear Medicine and Radiologist
MBBS, FRCR, FRCP, MSc, MA, MBA
Languages spoken: English
Dr Nicola Mulholland
Consultant in Nuclear Medicine and Radiologist
MBBS, FRCR, FRCP, MSc, MA, MBA
Languages spoken: English
Appointments available at:
Cromwell HospitalPatient Age Group
AdultsYear qualified
1995Specialties
Nuclear medicineGender
FemaleClinical Interests
Imaging including PET-CT, SPECT-CT, and WB-MRI; cross-sectional radiology; cancer therapies, including peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours (NET), radioligand therapy (RLT) for prostate cancer, and selective internal radioembolisation therapy for liver cancer.
About Dr Nicola Mulholland
Dr Nicola Mulholland is a consultant in nuclear medicine and radiology at Cromwell Hospital, specialising in radionuclide radiotherapy, functional imaging with PET-CT and WB-MRI, cross-sectional radiology, and cancer.
Dr Mulholland received her medical degree from the University of London in 1995 and completed dual training in clinical radiology and nuclear medicine. She became a Fellow of the Royal College of Physicians in 1999 and a Fellow of the Royal College of Radiologists in 2004.
Dr Mulholland offers molecular radiotherapy including radioiodine therapy for thyroid disease, peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours (NET), radioligand therapy (RLT) for prostate cancer, and selective internal radioembolisation therapy for liver cancer. She has a high level of expertise in hybrid imaging, including PET-CT and SPECT-CT, as well as expertise in MRI, cardiac CT angiography, and haemato-oncology.
Dr Mulholland is the Clinical Director of Cancer, Head of Nuclear Medicine and PET-CT, and Honorary Senior Lecturer at King's College Hospital. She has research interests in the use of imaging biomarkers in haemato-oncology and novel molecular radiotherapy techniques.
Dr Mulholland received her medical degree from the University of London in 1995 and completed dual training in clinical radiology and nuclear medicine. She became a Fellow of the Royal College of Physicians in 1999 and a Fellow of the Royal College of Radiologists in 2004.
Dr Mulholland offers molecular radiotherapy including radioiodine therapy for thyroid disease, peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours (NET), radioligand therapy (RLT) for prostate cancer, and selective internal radioembolisation therapy for liver cancer. She has a high level of expertise in hybrid imaging, including PET-CT and SPECT-CT, as well as expertise in MRI, cardiac CT angiography, and haemato-oncology.
Dr Mulholland is the Clinical Director of Cancer, Head of Nuclear Medicine and PET-CT, and Honorary Senior Lecturer at King's College Hospital. She has research interests in the use of imaging biomarkers in haemato-oncology and novel molecular radiotherapy techniques.
NHS Base (trust)
King's College Hospital NHS Foundation Trust
Professional memberships
Royal College of Physicians, Royal College of Radiologists (RCR)
